Keyphrases
Denmark
100%
Escherichia Coli
41%
Methicillin-resistant Staphylococcus Aureus
34%
Bacteremia
28%
Antibiotics
24%
COVID-19
24%
Staphylococcus Aureus
22%
Whole Genome Sequencing
20%
National Cohort Study
18%
Urinary Tract Infection
18%
Confidence Interval
18%
Vancomycin-resistant Enterococci
16%
Copenhagen
15%
Risk Factors
15%
Staphylococcus Aureus Bacteremia
14%
Enterococcus Faecium
14%
Antibiotic Treatment
12%
Epidemiology
11%
Fecal Microbiota Transplantation
11%
Inflammatory Bowel Disease
11%
Bloodstream Infection
11%
Core Genome multilocus Sequence Typing (cgMLST)
10%
Pseudomonas Aeruginosa (P. aeruginosa)
10%
Europe
10%
Blood Culture
9%
Antimicrobial Susceptibility
9%
Pneumocystis Carinii
9%
Virus
9%
Irritable Bowel Syndrome
9%
Antimicrobial Resistance
9%
Quantitative PCR
9%
Cefepime
9%
Klebsiella Pneumoniae (K. pneumoniae)
9%
Chronic Obstructive Pulmonary Disease
8%
Odds Ratio
8%
Population-based
8%
Ulcerative Colitis
8%
Pivmecillinam
8%
Plasmid
8%
Hepatitis C Virus
8%
Matched Cohort Study
7%
Antibiotic Use
7%
Penicillin
7%
Meningitis
7%
30-day Mortality
7%
Community-acquired
7%
Antimicrobial Therapy
7%
University Hospital
7%
Streptococcus Pneumoniae
7%
Piperacillin-tazobactam
7%
Hepatitis C Virus Genotypes
7%
VanA
6%
Lyme Neuroborreliosis
6%
Human Immunodeficiency Virus Type 1 (HIV-1)
6%
Vancomycin
6%
Infective Endocarditis
6%
Clostridium Difficile Infection
6%
ÎČ-lactamase
6%
Tuberculosis
6%
Antimicrobial
6%
Microscopy
6%
Crohn's Disease
6%
Urine Samples
6%
Sequence Type
6%
Infectious Diseases
5%
Fungemia
5%
Systematic Meta-analysis
5%
Pneumocystis Jirovecii
5%
Meticillin-resistant Staphylococcus Aureus
5%
Pneumonia
5%
Sepsis
5%
Randomized Controlled Trial
5%
Pulsed-field Gel Electrophoresis
5%
Microorganisms
5%
Ciprofloxacin
5%
Retrospective Cohort Study
5%
Comorbidity
5%
Spa-type
5%
Community-associated
5%
Population-based Cohort Study
5%
Genotype
5%
Enterococcus
5%
HIV Patients
5%
Clinical Significance
5%
Hazard Ratio
5%
Escherichia Coli Isolates
5%
Antibiotic Resistance
5%
Incidence Rate
5%
Urinary Tract
5%
C.glabrata
5%
Placebo
5%
Procalcitonin
5%
Clinical Microbiology
5%
Pregnant Women
5%
Varicella Zoster Virus
5%
Mortality Rate
5%
Healthy Controls
5%
Immunology and Microbiology
Escherichia coli
46%
Methicillin-Resistant Staphylococcus Aureus
38%
Staphylococcus Aureus
32%
Prevalence
24%
Infectious Agent
22%
Enterococcus faecium
20%
Whole Genome Sequencing
19%
Urinary Tract
19%
Polymerase Chain Reaction
17%
Lineages
15%
Antimicrobial Resistance
15%
Vancomycin-Resistant Enterococcus
14%
Multilocus Sequence Typing
14%
Antibiotic Sensitivity
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Hepatitis C Virus
9%
Plasmid
9%
Pneumocystis Carinii
8%
Microbiology
8%
Human Immunodeficiency Virus
8%
Clinical Microbiology
8%
Mouse
8%
Ulcerative Colitis
7%
Minimum Inhibitory Concentration
7%
Microorganism
7%
Klebsiella pneumoniae
7%
Inflammatory Bowel Disease
7%
Feces microflora
7%
Real Time Polymerase Chain Reaction
7%
Serotype
6%
Penicillin
6%
Monospecific Antibody
6%
Pseudomonas aeruginosa
6%
Phylogeny
6%
Crohn's Disease
6%
Hepatitis C
5%
Streptococcus Pneumoniae
5%
Single Nucleotide Polymorphism
5%
Genome Sequencing
5%
Enterococcus
5%
Medicine and Dentistry
Infection
36%
Cohort Analysis
30%
Antibiotics
17%
Diagnosis
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Bacteremia
15%
COVID-19
12%
Prevalence
12%
Escherichia coli
11%
Disease
11%
Human Immunodeficiency Virus
11%
Pathogen
11%
Bloodstream Infection
10%
Antibiotic Therapy
9%
Cohort Effect
9%
Blood Culture
9%
Methicillin Resistant Staphylococcus Aureus
8%
Staphylococcus Aureus
7%
Polymerase Chain Reaction
7%
Fecal Microbiota Transplantation
7%
Meningitis
7%
Childbirth
6%
Odds Ratio
6%
Symptom
6%
Urinary Tract Infection
6%
Placebo
5%
Hazard Ratio
5%
Staphylococcal Bacteremia
5%
Intensive Care Unit
5%
Irritable Bowel Syndrome
5%